Altarac David
Insider CIK 1792615 · ETTX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 92,307 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 50,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer | 2022-07-11 | 2022-07-11 | 150,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | U Tender | 2022-07-07 | 2022-07-11 | 17,572 | $2.20 | $38.7K | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2022-01-18 | 2022-01-19 | 125,000 | — | $0 | 167,572 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | F Tax w/h | 2021-11-02 | 2021-11-03 | 3,669 | $2.94 | $10.8K | 42,572 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2021-10-19 | 2021-10-20 | 25,000 | — | $0 | 50,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | S Sale | 2021-10-19 | 2021-10-20 | 3,759 | $3.19 | $12.0K | 46,241 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 92 | — | $0 | 92,307 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 120,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2021-01-15 | 2021-01-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2020-01-23 | 2020-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2019-11-04 | 2019-11-06 | 120,000 | — | $0 | 120,000 | SEC↗ |